Yaletown Capital Corp.
TSX VENTURE : YCC

October 07, 2010 11:54 ET

Yaletown Announces Change in Year-End

RICHMOND, BRITISH COLUMBIA--(Marketwire - Oct. 7, 2010) - Yaletown Capital Corp. ("Yaletown", the "Company") (TSX VENTURE:YCC) announces that Pursuant to Part 4 of National Instrument 51-102, Continuous Disclosure Obligations, that it has decided to change its financial year-end to June 30 in each calendar year. The change is being undertaken so that Yaletown's interim reporting periods will become coterminous with that of its subsidiary, 0695955 B.C. Ltd. carrying on business as "Freedom Bionics", the Company's acquisition under its Qualifying Transaction.

Yaletown's old financial year-end was April 30.
Yaletown's new financial year-end will be June 30.
The last day of Yaletown's old financial year-end was April 30, 2009.
The last day of Yaletown's transition year-end was June 30, 2010.

The tables below list the periods, including the comparative reporting periods, to be covered in the interim and annual financial statements for Yaletown's transition year (April 30, 2009 - June 30, 2010) and its new financial year (June 30, 2010 - June 30, 2011), together with the filing deadlines prescribed by section 4.2 and 4.4 of National Instrument No. 51-102:

A. Transition Year (April 30, 2009 - June 30, 2010)

Financial Statements to File Comparison Financial Statements Filing Deadline
12 months ending Apr. 30, 2010 12 months ending Apr. 30, 2009 Aug. 28, 2010

B. New Financial Year (June 30, 2010 - June 30, 2011)

Financial Statements to File Comparison Financial Statements Filing Deadline
12 months ending Jun. 30, 2010 12 months ending Jun. 30, 2009 Oct. 28, 2010
3 months ending Sept. 30, 2010 3 months ending Sept. 30, 2009 Nov. 29, 2010
6 months ending Dec. 31, 2010 6 months ending Dec. 31, 2009 Mar. 1, 2011
9 months ending Mar. 31, 2011 9 months ending Mar. 31, 2010 May 29, 2011
12 months ending Jun. 30, 2011 12 months ending Jun. 30, 2010 Oct. 28, 2011

About Freedom Bionics and Yaletown Capital Corporation

Freedom Bionics is a subsidiary of Yaletown Capital Corporation, specialising in the development of software, products and services for Health Care markets. Yaletown Capital Corporation is listed on the TSX-Venture Exchange under the symbol "YCC".

On Behalf of the Board of Directors

Douglas Kind, President and C.E.O.

Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.

Contact Information